保妇康栓治疗宫颈CIN合并高危HPV感染的临床观察  

Clinical observation on treating CIN plus HPV infection with Baofukang suppository

作　　者：陈春娟[1] 

机构地区：[1]焦作市人民医院,河南焦作454002

出　　处：《中医临床研究》2014年第20期55-56,共2页Clinical Journal Of Chinese Medicine

摘　　要：目的：探讨保妇康栓对治疗宫颈CIN合并高危HPV感染患者的疗效。方法：CIN合并高危HPV阳性患者110例，随机分成两组，观察组55例，LEEP刀术后给予保妇康栓阴道内放置治疗3个月；对照组55例，LEEP刀术后不做其他治疗。术后3～6个月随访，进行HPV检测。结果：治疗组术后3、6个月后，55例HPV转阴分别为38例、52例，转阴率分别为69.09%、94.05%；对照组术后3、6个月后复查，55例HPV转阴分别为21例、42例，转阴率分别为38.18%、76.36%。两组相比，差异均有统计学意义（P〈0.01）。结论：保妇康栓是宫颈CIN合并高危HPV感染术后治疗的有效药物，值得临床推广。To investigate clinical efficacy of Baofukang suppository on CIN plus HPV infection. Methods： 110 HPV-positive patients were randomly divided into two groups, the control group underwent LEEP operation, and the treatment was added Baofukang suppository for 3 months. In 3~6 months, patients were followed up with HPV testing. Results：At third and sixth month, in the treatment, the negative conversion rates were 69.09%（38） and 94.05%（52） respectively;in the control, the negative conversion rates were 38.18%（21） and 76.36%（42）. The difference was statistical significant （P〈0.01）. Conclusion：Baofukang suppository was effective on CIN plus HPV infection, and worthy of clinical promotion.

关 键 词：宫颈CIN 高危HPV感染 保妇康栓 

分 类 号：R339.22[医药卫生—人体生理学]